1649 related articles for article (PubMed ID: 12057007)
1. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
2. The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells.
Yu Z; Kone BC
J Am Soc Nephrol; 2004 Mar; 15(3):585-91. PubMed ID: 14978160
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases augment cytokine induction of the iNOS gene.
Yu Z; Zhang W; Kone BC
J Am Soc Nephrol; 2002 Aug; 13(8):2009-17. PubMed ID: 12138131
[TBL] [Abstract][Full Text] [Related]
4. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.
Ganster RW; Taylor BS; Shao L; Geller DA
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8638-43. PubMed ID: 11438703
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo.
Chantôme A; Pance A; Gauthier N; Vandroux D; Chenu J; Solary E; Jeannin JF; Reveneau S
J Biol Chem; 2004 Jun; 279(23):23953-60. PubMed ID: 15033982
[TBL] [Abstract][Full Text] [Related]
6. alpha-MSH inhibits induction of C/EBPbeta-DNA binding activity and NOS2 gene transcription in macrophages.
Gupta AK; Diaz RA; Higham S; Kone BC
Kidney Int; 2000 Jun; 57(6):2239-48. PubMed ID: 10844594
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription.
Yu Z; Kone BC
J Biol Chem; 2004 Nov; 279(45):46954-61. PubMed ID: 15308624
[TBL] [Abstract][Full Text] [Related]
8. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
[TBL] [Abstract][Full Text] [Related]
11. Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation.
Deng WG; Wu KK
J Immunol; 2003 Dec; 171(12):6581-8. PubMed ID: 14662860
[TBL] [Abstract][Full Text] [Related]
12. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
13. A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells.
Teng X; Zhang H; Snead C; Catravas JD
Gen Pharmacol; 2000 Jan; 34(1):9-16. PubMed ID: 10793263
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
[TBL] [Abstract][Full Text] [Related]
15. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
[TBL] [Abstract][Full Text] [Related]
16. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells.
Kolyada AY; Madias NE
Mol Med; 2001 May; 7(5):329-43. PubMed ID: 11474579
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation.
Majano P; Lara-Pezzi E; López-Cabrera M; Apolinario A; Moreno-Otero R; García-Monzón C
Hepatology; 2001 Dec; 34(6):1218-24. PubMed ID: 11732012
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions.
Ganster RW; Guo Z; Shao L; Geller DA
J Interferon Cytokine Res; 2005 Nov; 25(11):707-19. PubMed ID: 16318585
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA.
Lim S; Kang KW; Park SY; Kim SI; Choi YS; Kim ND; Lee KU; Lee HK; Pak YK
Biochem Pharmacol; 2004 Aug; 68(4):719-28. PubMed ID: 15276079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]